Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

NCT00131287 is registered in ClinicalTrials.gov with ECbiotech Taiwan as lead sponsor.

NCT NCT00131287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00131287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)
Lead sponsor
ECbiotech Taiwan
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2005
Completion date
December 31, 2006
Enrollment
108
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type ii